Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity
- PMID: 1620119
- PMCID: PMC364525
- DOI: 10.1128/mcb.12.7.3107-3116.1992
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity
Abstract
Previous cotransfection experiments had demonstrated that ectopic expression of the lymphocyte-specific transcription factor Oct2 could efficiently activate a promoter containing an octamer motif. Oct2 expression was unable to stimulate a multimerized octamer enhancer element in HeLa cells, however. We have tested a variety of Oct2 isoforms generated by alternative splicing for the capability to activate an octamer enhancer in nonlymphoid cells and a B-cell line. Our analyses show that several Oct2 isoforms can stimulate from a remote position but that this stimulation is restricted to B cells. This result indicates the involvement of either a B-cell-specific cofactor or a specific modification of a cofactor or the Oct2 protein in Oct2-mediated enhancer activation. Mutational analyses indicate that the carboxy-terminal domain of Oct2 is critical for enhancer activation. Moreover, this domain conferred enhancing activity when fused to the Oct1 protein, which by itself was unable to stimulate from a remote position. The glutamine-rich activation domain present in the amino-terminal portion of Oct2 and the POU domain contribute only marginally to the transactivation function from a distal position.
Similar articles
-
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.EMBO J. 1994 Apr 1;13(7):1654-63. doi: 10.1002/j.1460-2075.1994.tb06429.x. EMBO J. 1994. PMID: 8157005 Free PMC article.
-
Multiple Oct2 isoforms are generated by alternative splicing.Nucleic Acids Res. 1991 Jan 11;19(1):43-51. doi: 10.1093/nar/19.1.43. Nucleic Acids Res. 1991. PMID: 2011512 Free PMC article.
-
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms.Nucleic Acids Res. 1994 Oct 11;22(20):4250-8. doi: 10.1093/nar/22.20.4250. Nucleic Acids Res. 1994. PMID: 7937153 Free PMC article.
-
Molecular principles of Oct2-mediated gene activation in B cells.Immunobiology. 1995 Jul;193(2-4):161-70. doi: 10.1016/S0171-2985(11)80540-1. Immunobiology. 1995. PMID: 8530140 Review.
-
Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression.FASEB J. 1990 Mar;4(5):1444-9. doi: 10.1096/fasebj.4.5.2407588. FASEB J. 1990. PMID: 2407588 Review.
Cited by
-
Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator.Nucleic Acids Res. 2004 Mar 5;32(4):1577-83. doi: 10.1093/nar/gkh327. Print 2004. Nucleic Acids Res. 2004. PMID: 15004244 Free PMC article.
-
The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain.Mol Cell Biol. 1997 Jan;17(1):154-62. doi: 10.1128/MCB.17.1.154. Mol Cell Biol. 1997. PMID: 8972195 Free PMC article.
-
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.EMBO J. 1995 Mar 15;14(6):1198-208. doi: 10.1002/j.1460-2075.1995.tb07103.x. EMBO J. 1995. PMID: 7720710 Free PMC article.
-
Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.Nucleic Acids Res. 1996 May 15;24(10):1913-20. doi: 10.1093/nar/24.10.1913. Nucleic Acids Res. 1996. PMID: 8657574 Free PMC article.
-
An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells.Mol Cell Biol. 1993 May;13(5):2919-28. doi: 10.1128/mcb.13.5.2919-2928.1993. Mol Cell Biol. 1993. PMID: 8474450 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources